Inscrição na biblioteca: Guest
Critical Reviews™ in Oncogenesis

Publicou 4 edições por ano

ISSN Imprimir: 0893-9675

ISSN On-line: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Volume 20, 2015 Edição 5-6

DOI: 10.1615/CritRevOncog.v20.i5-6

Preface: Oncogenic Biomarkers and Signal Transduction Devasis Chatterjee
pp. vi-vii
DOI: 10.1615/CritRevOncog.v20.i5-6.10
In Memorium: Lee Goodglick Sandra Goodglick, W. Goodglick
329 pages
DOI: 10.1615/CritRevOncog.v20.i5-6.20
Lee Goodglick−In Fond Memory Michael Fishbein
331 pages
DOI: 10.1615/CritRevOncog.v20.i5-6.30
A Year On Jonathan Braun
333 pages
DOI: 10.1615/CritRevOncog.v20.i5-6.40
Dr. Lee Goodglick: A Valuable Collaborator and A Dear Friend Eleftherios Diamandis
335 pages
DOI: 10.1615/CritRevOncog.v20.i5-6.50
In Memory of Lee Goodglick: A Friend and A Scholar Benjamin Bonavida
pp. 337-338
DOI: 10.1615/CritRevOncog.v20.i5-6.60
Clinical Trials in Non-Small Cell Lung Cancer with Biomarker-Driven Treatment Allocation: Ready or Not, Here We Come Edward B. Garon, Phillip A. Abarca, Jennifer L. Strunck, Danielle Nameth, Catherine Neumann, Brian Wolf, Kevin Y. Kim, Caitlin Marx, Robert M. Elashoff
pp. 339-347
DOI: 10.1615/CritRevOncog.v20.i5-6.70
Non-Small Cell Lung Cancers in Women and Men: Differences in Biology, Behavior, and Outcomes Vei H. Mah
pp. 349-355
DOI: 10.1615/CritRevOncog.v20.i5-6.80
Liquid Biopsies in the Screening of Oncogenic Mutations in NSCLC and its Application in Targeted Therapy Jason H. Tang , David Chia
pp. 357-371
DOI: 10.1615/CritRevOncog.v20.i5-6.90
Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer Nalo Hamilton, Diana Marquez-Garban, Vei H. Mah, Yahya Elshimali, David Elashoff, Edward B. Garon, Jaydutt Vadgama, Richard Pietras
pp. 373-390
DOI: 10.1615/CritRevOncog.v20.i5-6.100
Regulation of FAK Activity by Tetraspan Proteins: Potential Clinical Implications in Cancer Yu Qin, Shabnam Mohandessi, Lynn Gordon, Madhuri Wadehra
pp. 391-405
DOI: 10.1615/CritRevOncog.v20.i5-6.110
Extracellular Vesicle-Mediated Reversal of Paclitaxel Resistance in Prostate Cancer Justin Q. Wang, Austin DeChalus, Devin N. Chatterjee, Evan T. Keller, Atsushi Mizokami, Giovanni Camussi, Andrew R. Mendelsohn, Joseph F. Renzulli II, Peter J. Quesenberry, Devasis Chatterjee
pp. 407-417
DOI: 10.1615/CritRevOncog.v20.i5-6.120
Hypoxia-Induced Signaling Promotes Prostate Cancer Progression: Exosomes Role as Messenger of Hypoxic Response in Tumor Microenvironment Gagan Deep, Gati K. Panigrahi
pp. 419-434
DOI: 10.1615/CritRevOncog.v20.i5-6.130
Review of the GAS3 Family of Proteins and their Relevance to Cancer Negin Ashki, Lynn Gordon, Madhuri Wadehra
pp. 435-447
DOI: 10.1615/CritRevOncog.v20.i5-6.140
Drug Development for Metastasis Prevention Yari Fontebasso, Steven M. Dubinett
pp. 449-473
DOI: 10.1615/CritRevOncog.v20.i5-6.150
Dynamins and BAR Proteins−Safeguards against Cancer Anna C. Sundborger , Jenny E. Hinshaw
pp. 475-484
DOI: 10.1615/CritRevOncog.v20.i5-6.160
Emerging Receptor Tyrosine Kinase Drug Targets: Implications for Antibody-Based Therapies for Oncology and Immunologic Disorders Theresa M. LaVallee, Diego Alvarado, Andrew J. Garton, E. Sergio Trombetta, Richard Gedrich, Gerald McMahon
pp. 485-508
DOI: 10.1615/CritRevOncog.v20.i5-6.170
Journey from Jumping Genes to Gene Therapy Katharine A. Whartenby
pp. 509-518
DOI: 10.1615/CritRevOncog.v20.i5-6.180
Epigenetic/Genetic Mismatch: Using Transdifferentiation as a Potential Cancer Therapy to Exploit the Cell Type Specificity of Cancer Andrew R. Mendelsohn, Jennifer L. Lei, Devasis Chatterjee
pp. 519-535
DOI: 10.1615/CritRevOncog.v20.i5-6.190
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa Políticas de preços e assinaturas Begell House Contato Language English 中文 Русский Português German French Spain